Global leaders to gather in London for 5th Regenerative Aesthetic Surgery Symposium this September
The 5th Regenerative Aesthetic Surgery Symposium is set to take place on 25-26 September 2025 in London, in association with the Clinical Cosmetic Regenerative (CCR) Congress.
This prestigious two-day event will bring together the world’s foremost experts and innovators in regenerative surgery to share pioneering techniques, cutting-edge technologies and breakthrough research that are redefining the landscape of cosmetic, aesthetic and reconstructive surgery.
Hosted by an esteemed Scientific Committee including Mr Tunc Tiryaki, Dr George Christopoulos and Dr Steven Cohen, the symposium promises to be a landmark occasion for knowledge exchange, surgical excellence and global collaboration.
Day One: Thursday 25 September will feature a full-day agenda dedicated to the latest developments in regenerative surgery, offering delegates a deep dive into surgical advancements and forward-thinking practices.
Day Two: Friday 26 September will offer delegates access to the CCR Congress, where the regenerative aesthetic medicine programme will focus on minimally invasive techniques that complement and enhance surgical approaches.
“This symposium is a celebration of progress and a platform for shaping the future of regenerative surgery,” says Mr Tiryaki. "We are proud to welcome colleagues from around the world to London for this unique gathering of innovation and insight.”
Shannon Kilgariff, Event Manager of CCR adds, “We are incredibly honoured to host the 5th International Regenerative Surgery Symposium at CCR. It is a privilege to provide a platform for the world’s leading minds in regenerative surgery to come together to share knowledge, inspire progress and shape the future of our industry.”
The Regenerative Aesthetic Surgery Symposium continues its legacy of creating dialogue between science, technology and clinical practice, with the ultimate goal of improving patient outcomes and advancing the field of regenerative medicine.